Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease

M Hoenigl, A Arastehfar, MC Arendrup… - Clinical Microbiology …, 2024‏ - journals.asm.org
Fungal infections are on the rise, driven by a growing population at risk and climate change.
Currently available antifungals include only five classes, and their utility and efficacy in …

Antifungal resistance and the role of new therapeutic agents

A Logan, A Wolfe, JC Williamson - Current Infectious Disease Reports, 2022‏ - Springer
Abstract Purpose of Review Advances in health care over time have led to an evolution in
the epidemiology of invasive fungal infections. There is an increasing concern for antifungal …

Candida auris: A Quick Review on Identification, Current Treatments, and Challenges

L Černáková, M Roudbary, S Brás, S Tafaj… - International journal of …, 2021‏ - mdpi.com
Candida auris is a novel and major fungal pathogen that has triggered several outbreaks in
the last decade. The few drugs available to treat fungal diseases, the fact that this yeast has …

[HTML][HTML] What Do We Know about Candida auris? State of the Art, Knowledge Gaps, and Future Directions

V Garcia-Bustos, MD Cabanero-Navalon, A Ruiz-Saurí… - Microorganisms, 2021‏ - mdpi.com
Candida auris has unprecedently emerged as a multidrug resistant fungal pathogen,
considered a serious global threat due to its potential to cause nosocomial outbreaks and …

Emerging and future strategies in the management of recalcitrant Candida auris

N Bandara, L Samaranayake - Medical Mycology, 2022‏ - academic.oup.com
Candida auris is an emerging, multi drug resistant fungal pathogen that has caused
infectious outbreaks in over 45 countries since its first isolation over a decade ago, leading …

Novel antifungal agents in clinical trials

SE Jacobs, P Zagaliotis, TJ Walsh - F1000Research, 2022‏ - pmc.ncbi.nlm.nih.gov
Invasive fungal diseases due to resistant yeasts and molds are an important and increasing
public health threat, likely due to a growing population of immunosuppressed hosts …

The antifungal pipeline for invasive fungal diseases: what does the future hold?

CF Neoh, W Jeong, DCM Kong… - Expert review of anti …, 2023‏ - Taylor & Francis
Introduction Over the last two decades, we have experienced pressing needs for new
additions to the antifungal armamentarium given the emergence of resistant fungi, the …

Impact of FKS1 Genotype on Echinocandin In Vitro Susceptibility in Candida auris and In Vivo Response in a Murine Model of Infection

D Sharma, RA Paul, SM Rudramurthy… - Antimicrobial agents …, 2022‏ - journals.asm.org
Echinocandins are frontline antifungal agents in the management of invasive infections due
to multidrug resistant Candida auris. The study aimed to evaluate echinocandin resistance …

Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris

M Billamboz, Z Fatima, S Hameed, S Jawhara - Microorganisms, 2021‏ - mdpi.com
Invasive fungal infections represent an expanding threat to public health. During the past
decade, a paradigm shift of candidiasis from Candida albicans to non-albicans Candida …

Azole resistance in Candida auris: mechanisms and combinatorial therapy

P Jangir, S Kalra, S Tanwar, VK Bari - Apmis, 2023‏ - Wiley Online Library
Multidrug resistance Candida auris is a dangerous fungal pathogen that is emerging at an
alarming rate and posing serious threats to public health. C. auris is associated with …